Imbruvica (ibrutinib) is a prescription drug used for certain kinds of cancer and graft-versus-host disease. Imbruvica comes as an oral tablet, capsule, and suspension (a type of liquid mixture).

Imbruvica is prescribed to treat:

To learn more about Imbruvica’s uses, see the “Is Imbruvica used for CLL?” and “Is Imbruvica used for other conditions?” sections.

Imbruvica basics

Imbruvica contains the active ingredient ibrutinib. It belongs to a group of drugs called kinase inhibitors.

Imbruvica is a brand-name medication. A generic version of the drug isn’t currently available.

Yes, Imbruvica is prescribed to treat chronic lymphocytic leukemia (CLL) in adults. This includes people who have CLL with a 17p deletion. (This is a change in your chromosomes, which make up your genes.)

CLL is a type of leukemia, which is a cancer that affects your blood and bone marrow. With CLL, your body makes abnormal lymphocytes (a type of white blood cell) in large numbers.

CLL is a slow-growing cancer that can take years to get worse. Many people with CLL don’t show symptoms for several years. Over time, CLL can lead to problems such as a low level of red blood cells and platelets.

Imbruvica works to treat CLL by targeting and blocking a certain enzyme (a type of protein) in your body. Blocking this enzyme stops cancer cells from growing.

In addition to CLL, Imbruvica also treats other conditions. See “Is Imbruvica used for other conditions?” for details.

Imbruvica is prescribed to treat chronic lymphocytic leukemia (CLL) and other conditions, such as:

  • Small lymphocytic leukemia (SLL) in adults: This is a type of leukemia (blood cancer) that happens in your lymph nodes (a part of your immune system). Like CLL, it causes your body to make abnormal lymphocytes (a type of white blood cell) in large numbers. SLL is a slow-growing cancer that can take years to get worse. Imbruvica may be used to treat SLL in people who do or do not have a 17p deletion (a change in your chromosomes, which make up your genes).
  • Waldenstrom macroglobulinemia (WM) in adults: WM is a rare type of non-Hodgkin’s lymphoma that affects your plasma cells (a type of white blood cell). It causes your body to make too much of an immune system protein called IgM. This makes your blood thicker than usual, and your organs have a hard time working properly because of this.
  • Chronic (long lasting) graft-versus-host disease (cGVHD): cGVHD can happen after you receive a stem cell transplant. With cGVHD, the transplanted cells attack your own body. Imbruvica is only used to treat cGVHD in people who have tried another treatment, but their condition got worse. Imbruvica can be prescribed for cGVHD in adults and in children 1 year and older.

See “Is Imbruvica used for CLL?” for details about Imbruvica’s use for this type of cancer.

Costs of prescription drugs can vary depending on many factors. These include what your insurance plan covers and which pharmacy you use. You can visit the Imbruvica manufacturer’s website to see their support options, including an Imbruvica copay card.

If you have questions about how to pay for your prescription, talk with your doctor or pharmacist.

Like most drugs, Imbruvica may cause mild or serious side effects. The following lists describe some of the more common side effects. These lists don’t include all possible side effects.

Keep in mind that side effects of a drug can depend on:

  • your age
  • other health conditions you have
  • other medications you take

Your doctor or pharmacist can tell you more about the potential side effects of Imbruvica. They can also suggest ways to help reduce side effects.

Mild side effects

The following list includes some of the mild side effects Imbruvica can cause. To learn about other mild side effects, talk with your doctor or pharmacist, or read Imbruvica’s prescribing information.

Mild side effects reported in people using Imbruvica varied with the condition being treated. But they included:

For more information about some of these side effects, see the “Side effect focus” section.

Mild side effects of many drugs may go away within a few days or a couple of weeks. But if they become bothersome, talk with your doctor or pharmacist.

Serious side effects

Serious side effects from Imbruvica can occur, but they aren’t common. If you have serious side effects, call your doctor right away. But if you think you’re having a medical emergency, call 911 or your local emergency number.

Serious side effects of Imbruvica that have been reported include:

For more information about some of these side effects, see the “Side effect focus” section.

Side effect focus

Learn more about some of the side effects Imbruvica may cause.

Joint pain

It’s possible that you’ll have joint pain from taking Imbruvica. This side effect usually isn’t severe.

Joint pain was common in people taking the drug for blood cancers in studies. But it wasn’t reported by people who took Imbruvica to treat chronic (long lasting) graft-versus-host disease (cGVHD).

What might help

Talk with your doctor if you have joint pain while taking Imbruvica. They may be able to suggest treatments for pain relief.

Bleeding

Bleeding is a serious side effect that’s possible with Imbruvica treatment. Serious bleeding wasn’t common in studies, but it can be life threatening in rare cases.

Your risk of bleeding while taking Imbruvica may be higher if you take other medications that also increase this risk. These include:

It’s important to note that your risk of bleeding from certain surgeries may be higher while you’re taking Imbruvica.

What might help

Call your doctor right away if you have any of the following symptoms of bleeding:

But if your symptoms feel life threatening, call 911 or your local emergency number.

Before taking Imbruvica, tell your doctor about all the medications you take, including any over-the-counter medications (such as aspirin). Your doctor can check for any drug interactions with Imbruvica. Based on what they find, they may decide to change your treatment plan. This may include recommending a medication other than Imbruvica for your condition.

Mouth sores

Mouth sores are a common side effect reported by people taking Imbruvica in studies. These sores can happen anywhere in your mouth. They may feel like a small cut.

Mouth sores were reported by people using Imbruvica for either blood cancers or cGVHD. But they were more common in people with cGVHD.

What might help

Mouth sores from Imbruvica may go away on their own after a few days or weeks. But if you develop mouth sores that are bothersome or won’t go away, call your doctor.

Your doctor may recommend treatments to make you more comfortable. They may also suggest you try a medication other than Imbruvica.

Allergic reaction

Some people may have an allergic reaction to Imbruvica. Although allergic reactions weren’t reported in studies of Imbruvica, they can still occur.

Symptoms of a mild allergic reaction can include:

  • skin rash
  • itchiness
  • flushing (temporary warmth, redness, or deepening of skin color)

A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include swelling under your skin, typically in your eyelids, lips, hands, or feet. They can also include swelling of your tongue, mouth, or throat, which can cause difficulty breathing.

Call your doctor right away if you have an allergic reaction to Imbruvica. But if you think you’re having a medical emergency, call 911 or your local emergency number.

Your doctor will recommend the dosage of Imbruvica that’s right for you. The following are commonly used dosages, but always take the dosage your doctor prescribes.

Forms and strengths

Imbruvica is available as capsules, tablets, and a suspension (a type of liquid mixture) that you swallow.

Here’s a chart showing Imbruvica’s available forms and strengths:

Imbruvica capsulesImbruvica tabletsImbruvica suspension
70 milligrams (mg)140 mg70 mg per milliliter (mg/mL)
140 mg280 mg
420 mg

Recommended dosages

For adults and children 12 years and older, the recommended Imbruvica dosage is 420 mg once per day. Your doctor might prescribe Imbruvica capsules or tablets.

Children’s dosage

In children ages 1 to 12 years, the recommended Imbruvica dosage is 240 mg per meter squared (mg/m2) of body surface area.* Your child’s doctor will tell you exactly how many tablets or capsules your child should take, or how much of the oral suspension to give for each dose.

* Body surface area is a measurement calculated using weight and height.

Questions about Imbruvica’s dosage

Here are answers to a few common questions about taking Imbruvica.

  • What if I miss a dose of Imbruvica? If you miss a dose of Imbruvica, try to take it as soon as you remember. But if it’s the next day and you realize you missed a dose, simply skip the missed dose. Then take your next scheduled dose as usual. Do not take more than your regular dose to try and make up for the missed dose.
  • Will I need to use Imbruvica long term? What’s the treatment duration of this drug? You’ll likely take Imbruvica long term, unless you have unbearable side effects, or your condition gets worse during treatment. Exactly how long you’ll take the drug depends on your condition and how your body responds to treatment. Your doctor can tell you more about how long you’ll need to take Imbruvica.
  • How long does Imbruvica take to work? Imbruvica begins working as soon as you take a dose. But it may take some time before results can be detected on lab tests. In studies, people taking Imbruvica saw a response, on average, between a little over 1 month and about 4.5 months. The length of time varies depending on the condition Imbruvica is prescribed to treat.

Here are answers to some commonly asked questions about Imbruvica.

Is Imbruvica a chemotherapy or immunotherapy drug?

No, Imbruvica isn’t a chemotherapy drug or an immunotherapy drug. Imbruvica is called a kinase inhibitor. It’s a type of targeted therapy. This treatment targets the specific parts of cancer cells that help them grow and spread.

Chemotherapy drugs affect cells in your body that are quickly multiplying (making more cells). This includes cancer cells, but it also includes healthy cells. This is why chemotherapy drugs can cause so many side effects.

Imbruvica is also not an immunotherapy drug. Immunotherapy drugs work by boosting your own immune system or changing how it works in order to fight cancer cells.

To learn how Imbruvica works, see the “How does Imbruvica work?” section.

How does Imbruvica work? What’s its half-life?

Imbruvica’s mechanism of action (how it works) is to target and block a certain enzyme (type of protein). The enzyme in your body that Imbruvica targets is called Bruton’s tyrosine kinase (BTK).

Blocking BTK keeps cancer cells from growing. This is how Imbruvica treats certain types of cancer.

Blocking BTK also stops certain immune system cells from working. This is how Imbruvica works to treat chronic (long lasting) graft-versus-host disease (cGVHD).

Imbruvica has a half-life of about 4 to 6 hours. (A drug’s half-life is the time it takes for your body to get rid of half of a dose of the drug.)

If you’d like to learn more about how Imbruvica works, talk with your doctor or pharmacist.

Are there alternatives for Imbruvica?

Yes, there are alternatives to Imbruvica that can treat leukemia, lymphoma, or chronic graft-versus-host disease (cGVHD).

A few examples include:

Some may be a better fit for you than others. If you’re interested in finding an alternative to Imbruvica, talk with your doctor. They can tell you about the best treatment option for your condition.

Can I take Imbruvica if I’m having surgery?

Maybe. Talk with your doctor if you plan on having any type of surgery, including dental procedures, while taking Imbruvica.

Keep in mind that Imbruvica can increase your risk of bleeding. So your doctor may have you pause from taking Imbruvica about 3 to 7 days before your surgery. This helps prevent severe bleeding during your procedure. But you should not stop taking Imbruvica unless your doctor specifically tells you to do so.

Imbruvica and Venclexta are both used to treat chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL). But they’re used to treat some different conditions as well.

Imbruvica and Venclexta both belong to a group of medications called targeted therapies. But they contain different active ingredients and work in slightly different ways. Because of this, they may cause different side effects.

You can talk with your doctor to learn which drug is best for you.

Your doctor will explain how you should take Imbruvica. They’ll also explain how much to take and how often. Be sure to follow your doctor’s instructions.

Taking Imbruvica

Imbruvica comes as capsules, tablets, and an oral suspension. Each form is swallowed.

You should take Imbruvica with a glass of water. This includes the oral suspension form; be sure to drink a glass of water after swallowing a dose.

The suspension comes with oral dosing syringes to help you give the correct dose. It also comes with instructions for how to measure and give a dose.

Taking Imbruvica with other drugs

Depending on the condition it’s used to treat, Imbruvica may be used together with other drugs. Talk with your doctor if you have questions about taking Imbruvica with other drugs.

Questions about taking Imbruvica

Here are answers to a few common questions about taking Imbruvica.

  • Can Imbruvica be chewed, crushed, or split? No, you should not chew, crush, or split Imbruvica capsules or tablets. Imbruvica capsules and tablets should be swallowed whole. If you have difficulty swallowing capsules or tablets, check out this article. Or talk with your pharmacist or doctor. They can tell you whether you could take the Imbruvica oral suspension instead.
  • Should I take Imbruvica with food? Imbruvica may be taken with or without food. That said, you should take your dose with a glass of water.

Ask your doctor about the benefits and risks of treatment before you start taking Imbruvica. Tell them about all your health conditions and any medications you’re currently taking. These and other considerations are described here.

Interactions

Taking a medication with certain vaccines, foods, and other things can affect how the medication works. These effects are called interactions.

Before taking Imbruvica, be sure to tell your doctor about all medications you take, including prescription and over-the-counter types. Also, describe any vitamins, herbs, or supplements you use. Your doctor or pharmacist can tell you about any possible interactions with Imbruvica.

Interactions with drugs or supplements

Imbruvica can interact with several types of drugs, including:

This list does not contain all types of drugs that may interact with Imbruvica. Your doctor or pharmacist can tell you more about these interactions and any others that may occur with Imbruvica.

Other interactions

You should avoid drinking grapefruit juice or eating grapefruit while you’re taking Imbruvica. You should also avoid Seville oranges, which are sometimes called bitter oranges.

Both fruits can increase Imbruvica levels in your body, increasing your risk of side effects.

Talk with your doctor before you begin taking Imbruvica if you usually consume grapefruit or Seville oranges.

Warnings

Imbruvica may not be right for you if you have certain medical conditions or other factors that affect your health. Talk with your doctor about your health history before you take Imbruvica. Factors to consider include those in the following list:

Imbruvica and alcohol

There isn’t a known interaction between consuming alcohol and taking Imbruvica. But if you drink alcohol, it’s always best to check with your doctor about how much is safe for you based on your health and treatment plan.

Pregnancy and breastfeeding

It’s recommended that you do not take Imbruvica while pregnant or breastfeeding.

If you can become pregnant, your doctor will order a pregnancy test. They’ll confirm it’s negative before prescribing Imbruvica to you. While taking Imbruvica, you should use an effective form of birth control. And you should keep using it for at least 1 month after your last dose of Imbruvica.

You should also avoid breastfeeding while taking Imbruvica and for at least 1 week after your last dose. This is because the drug may cause serious side effects in a child who is breastfed.

Talk with your doctor about the safety of taking Imbruvica while you’re pregnant or breastfeeding.

Do not take more Imbruvica than your doctor prescribes. Taking more than this can lead to serious side effects.

What to do in case you take too much Imbruvica

Call your doctor if you think you’ve taken too much Imbruvica. You can also call 800-222-1222 to reach America’s Poison Centers or use its online resource. But if you have severe symptoms, immediately call 911 (or your local emergency number) or go to the nearest emergency room.

Q:

Will I need to have lab tests done while I’m taking Imbruvica? If so, what kind of tests and how often?

Anonymous

A:

Yes, you will. People taking Imbruvica need to have blood tests done monthly.

Depending on your health history, you may need blood tests more often. And other tests may be needed if you have certain side effects. These other tests could include an electrocardiogram (EKG), which checks how your heart is working.

If you want to know more about tests you may need while taking Imbruvica, talk with your doctor before and during treatment.

The Healthline Pharmacist TeamAnswers represent the opinions of our medical experts. All content is strictly informational and should not be considered medical advice.

Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.

Imbruvica images